People
Norm Armstrong is a partner in the Washington, D.C. office and co-chairs the firm's global Antitrust practice. Norm focuses on a wide range of antitrust matters including complex transactions, government civil and criminal investigations, and antitrust litigation. He advises clients on matters before the Federal Trade Commission (FTC), Department of Justice (DOJ) and multiple U.S. Federal and State courts, in addition to consumer protection issues. Norm's over 25 years of antitrust law experience in the public and private sectors allows him to support clients on their most important, high-profile transactions and disputes.
He advises clients on all aspects of U.S. and international competition law, including mergers and acquisitions, joint ventures and other strategic alliances, government civil and criminal investigations, private antitrust litigation and counseling. Norm is a former deputy director of the Federal Trade Commission (FTC) Bureau of Competition. He served in this role for six years overseeing three divisions and the regional offices that investigated anticompetitive transactions and conduct in an array of industries, including: healthcare, technology, pharmaceuticals, retail, consumer goods, energy, and entertainment. Prior to that, Norm served as deputy assistant director of the FTC's Bureau of Competition where he co-led some of the Commission's most high-profile litigation matters.
Norm is recognized by Law360 as a 2022 MVP Competition and as a leading antitrust practitioner by Chambers & Partners, The Legal 500, Global Competition Review, Who's Who Legal Competition, Best Lawyers in America and Lawdragon 500. He frequently lectures on a wide range of antitrust issues and is a former member of the ABA Antitrust Section's Long Range Planning Committee, co-chair of the ABA's Mergers and Acquisition Committee, and Vice Chair of the Pricing Conduct Committee.
J.D., Howard University School of Law
B.A., University of Virginia
District of Columbia
Maryland
American Bar Association Anitrust Section
American Health Lawyers Association
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
Representing BASF in asserting antitrust counterclaims against a competing automotive component manufacturer, Ingevity Corporation.
Representing Evangelical Community Hospital in the Department of Justice’s challenge to its collaboration with Geisinger Health.
Represented Hillrom in its $375 million acquisition of Bardy Diagnostics.
See more
August 23, 2023
FTC and DOJ Announce New Enforcement Actions Against Interlocking Directorates
August 14, 2023
FTC and DOJ Announce New Draft Merger Guidelines
July 10, 2023
FTC and DOJ jointly announced proposed changes to the HSR premerger notification form
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
Representing BASF in asserting antitrust counterclaims against a competing automotive component manufacturer, Ingevity Corporation.
Representing Evangelical Community Hospital in the Department of Justice’s challenge to its collaboration with Geisinger Health.
Represented Hillrom in its $375 million acquisition of Bardy Diagnostics.
See more
August 23, 2023
FTC and DOJ Announce New Enforcement Actions Against Interlocking Directorates
August 14, 2023
FTC and DOJ Announce New Draft Merger Guidelines
July 10, 2023
FTC and DOJ jointly announced proposed changes to the HSR premerger notification form
June 8, 2023
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2023 Guide
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
J.D., Howard University School of Law
B.A., University of Virginia
District of Columbia
Maryland
American Bar Association Anitrust Section
American Health Lawyers Association